# Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy

> **NCT00258180** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 3 (actual)

## Conditions studied

- Diarrhea
- Gastrointestinal Complications
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide

## Key facts

- **NCT ID:** NCT00258180
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08-15
- **Primary completion:** 2009-02-24
- **Final completion:** 2009-02-24
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2019-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00258180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00258180, "Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00258180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*